Insider transactions

EDGAR

Nuvation Bio Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
1 transactions, 25,000 shares
Sum of shares × price per share: 118,250
Open-market sales (code S)
13 transactions, 1,181,469 shares
Sum of shares × price per share: 7,602,288.2538

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 66

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-19 Filed 2026-08-21Hattersley Gary Officer: CHIEF SCIENTIFIC OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)100,0001.87
187,000

Derived: shares × price per share. Exact value 187000.00.

100,000Direct (D) Yes— Open filing 0001521111-26-000005 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Hattersley Gary Officer: CHIEF SCIENTIFIC OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)100,0007.0924
709,240

Derived: shares × price per share. Exact value 709240.0000.

0Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001521111-26-000005 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Hattersley Gary Officer: CHIEF SCIENTIFIC OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (100,000) — exercise price 1.87
Disposed (D)100,0000—400,000Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001521111-26-000005 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)39,9992.17
86,797.83

Derived: shares × price per share. Exact value 86797.83.

54,130Direct (D) No
F1
  • F1 Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026.
Open filing 0002039891-26-000008 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)11.97
1.97

Derived: shares × price per share. Exact value 1.97.

54,131Direct (D) No
F1
  • F1 Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026.
Open filing 0002039891-26-000008 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (39,999) — exercise price 2.17
Disposed (D)39,9990—662,333Direct (D) No
F2
  • F2 Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002039891-26-000008 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (1) — exercise price 1.97
Disposed (D)10—499,999Direct (D) No
F3
  • F3 Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002039891-26-000008 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)47,6682.17
103,439.56

Derived: shares × price per share. Exact value 103439.56.

60,341Direct (D) Yes— Open filing 0002039891-26-000006 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Sauvage Philippe Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)47,6686.0076
286,370.2768

Derived: shares × price per share. Exact value 286370.2768.

12,673Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.04. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0002039891-26-000006 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Sauvage Philippe Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (47,668) — exercise price 2.17
Disposed (D)47,6680—702,332Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002039891-26-000006 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Markel Stacy Officer: CHIEF PEOPLE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)90,3801.87
169,010.6

Derived: shares × price per share. Exact value 169010.60.

122,971Direct (D) Yes— Open filing 0001734780-26-000004 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Markel Stacy Officer: CHIEF PEOPLE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)34,6201.74
60,238.8

Derived: shares × price per share. Exact value 60238.80.

157,591Direct (D) Yes— Open filing 0001734780-26-000004 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Markel Stacy Officer: CHIEF PEOPLE OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)125,0006.0255
753,187.5

Derived: shares × price per share. Exact value 753187.5000.

32,591Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.085. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001734780-26-000004 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Markel Stacy Officer: CHIEF PEOPLE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (90,380) — exercise price 1.87
Disposed (D)90,3800—409,620Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001734780-26-000004 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Markel Stacy Officer: CHIEF PEOPLE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (34,620) — exercise price 1.74
Disposed (D)34,6200—220,190Direct (D) Yes
F4
  • F4 Option vests as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001734780-26-000004 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)63,0002.93
184,590

Derived: shares × price per share. Exact value 184590.00.

116,000Direct (D) Yes— Open filing 0001369453-26-000008 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)63,0006.0189
379,190.7

Derived: shares × price per share. Exact value 379190.7000.

53,000Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.08. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001369453-26-000008 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-24Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (63,000) — exercise price 2.93
Disposed (D)63,0000—152,250Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001369453-26-000008 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-11Mashal Robert Director
P

Open market or private purchase of non-derivative or derivative security

Class A Common Stock
Acquired (A)25,0004.73
118,250

Derived: shares × price per share. Exact value 118250.00.

225,000Indirect (I) By TrustNo
F1
  • F1 Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee.
Open filing 0002007102-26-000004 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26BLICKENSTAFF KIM D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0001238913-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Cui Xiangmin Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0001487815-26-000007 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26FALBERG KATHRYN E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0001206977-26-000006 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26VERNON W ANTHONY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0001369091-26-000003 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Mashal Robert Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0002007102-26-000002 Read from the filing’s XML Dispute this row
2026-05-21 Filed 2026-05-26Bazemore Robert B Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (123,397) — exercise price 4.79
Acquired (A)123,3970—123,397Direct (D) No
F1
  • F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Open filing 0001620152-26-000003 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Liu Dongfang Officer: CHIEF MEDICAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)50,0001.94
97,000

Derived: shares × price per share. Exact value 97000.00.

68,000Direct (D) Yes— Open filing 0001937915-26-000004 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Liu Dongfang Officer: CHIEF MEDICAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)50,0005.02
251,000

Derived: shares × price per share. Exact value 251000.00.

18,000Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001937915-26-000004 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Liu Dongfang Officer: CHIEF MEDICAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (50,000) — exercise price 1.94
Disposed (D)50,0000—430,000Direct (D) Yes
F3
  • F3 Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date
Open filing 0001937915-26-000004 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)36,7502.93
107,677.5

Derived: shares × price per share. Exact value 107677.50.

89,750Direct (D) Yes— Open filing 0001369453-26-000006 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)36,7505.0144
184,279.2

Derived: shares × price per share. Exact value 184279.2000.

53,000Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.05. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001369453-26-000006 Read from the filing’s XML Dispute this row
2026-04-17 Filed 2026-04-21Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (36,750) — exercise price 2.93
Disposed (D)36,7500—215,250Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001369453-26-000006 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)100,0001.87
187,000

Derived: shares × price per share. Exact value 187000.00.

153,000Direct (D) Yes— Open filing 0001369453-26-000005 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)100,0001.94
194,000

Derived: shares × price per share. Exact value 194000.00.

253,000Direct (D) Yes— Open filing 0001369453-26-000005 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)200,0004.5178
903,560

Derived: shares × price per share. Exact value 903560.0000.

53,000Direct (D) Yes
F1, F2
  • F1 Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
  • F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $4.44 to $4.64. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001369453-26-000005 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (100,000) — exercise price 1.87
Disposed (D)100,0000—400,000Direct (D) Yes
F3
  • F3 Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001369453-26-000005 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (100,000) — exercise price 1.94
Disposed (D)100,0000—300,000Direct (D) Yes
F4
  • F4 Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001369453-26-000005 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-05-26Cui Xiangmin Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (76,923) — exercise price 5.91
Acquired (A)76,9230—76,923Direct (D) No
F1, F2
  • F1 On March 3, 2026, the reporting person filed a Form 4 which, due to an administrative error, incorrectly reported that the reporting person was awarded 74,813 options to purchase Class A Common Stock on February 27, 2026. In fact, the reporting person was awarded 76,923 options to purchase Class A Common Stock on such date.
  • F2 Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date
Open filing 0001487815-26-000006 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Hung David Director · Officer: PRESIDENT AND CEO · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (1,995,012) — exercise price 5.91
Acquired (A)1,995,0120—1,995,012Direct (D) No
F1
  • F1 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001310880-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Cui Xiangmin Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (74,813) — exercise price 5.91
Acquired (A)74,8130—74,813Direct (D) No
F1
  • F1 Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001487815-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Makunje Moses Officer: SEE REMARKS
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Class A Common Stock
Acquired (A)50,7610—68,137Direct (D) No
F1, F2
  • F1 Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date.
  • F2 Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan.
Open filing 0002001938-26-000004 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Makunje Moses Officer: SEE REMARKS
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (224,439) — exercise price 5.91
Acquired (A)224,4390—224,439Direct (D) No
F3
  • F3 Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002001938-26-000004 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Hattersley Gary Officer: CHIEF SCIENTIFIC OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F1
  • F1 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001521111-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Markel Stacy Officer: CHIEF PEOPLE OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F2
  • F2 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001734780-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Wentworth Kerry Officer: CHIEF REGULATORY OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F2
  • F2 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001369453-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Hanley David C. Officer: CHIEF TECHNICAL OPERATIONS
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F1
  • F1 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001865826-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Sjogren Colleen Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F2
  • F2 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002017751-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Liu Dongfang Officer: CHIEF MEDICAL OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F1
  • F1 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0001937915-26-000003 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Sauvage Philippe Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Class A Common Stock (748,130) — exercise price 5.91
Acquired (A)748,1300—748,130Direct (D) No
F2
  • F2 Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Open filing 0002039891-26-000003 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Liu Dongfang Officer: CHIEF MEDICAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Class A Common Stock
Acquired (A)150,0002.93
439,500

Derived: shares × price per share. Exact value 439500.00.

168,000Direct (D) No— Open filing 0001937915-25-000010 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Liu Dongfang Officer: CHIEF MEDICAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Class A Common Stock
Disposed (D)150,0007.8217
1,173,255

Derived: shares × price per share. Exact value 1173255.0000.

18,000Direct (D) No
F1
  • F1 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001937915-25-000010 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 296

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Linden Advisors LP 75,584,000 PRN77,301,971 dollarsHigher by 23,000,000 Prior quarter: 52,584,000Open filing 0001193125-26-462390 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager52,668,484 SH294,943,510 dollarsHigher by 438,189 Prior quarter: 52,230,295Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Context Capital Management, LLC 52,000,000 PRN53,127,392 dollarsHigher by 22,000,000 Prior quarter: 30,000,000Open filing 0001301396-26-000010 Filed 2026-11-04 Dispute this row
BlackRock, Inc. Partly reported under another manager28,924,444 SH161,976,885 dollarsHigher by 1,293,607 Prior quarter: 27,630,837Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC 26,000,000 PRN26,622,344 dollarsHigher by 10,000,000 Prior quarter: 16,000,000Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Decheng Capital LLC 25,954,439 SH145,344,858 dollarsUnchanged Prior quarter: 25,954,439Open filing 0001104659-26-127247 Filed 2026-11-13 Dispute this row
TENOR CAPITAL MANAGEMENT COMPANY, L.P. 19,500,000 PRN20,033,780 dollarsUnchanged Prior quarter: 19,500,000Open filing 0001346554-26-000092 Filed 2026-11-16 Dispute this row
QVT Financial LP 15,500,000 PRN15,927,930 dollarsHigher by 8,500,000 Prior quarter: 7,000,000Open filing 0001193125-26-463263 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 12,152,903 SH68,056,257 dollarsHigher by 233,389 Prior quarter: 11,919,514Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
READYSTATE ASSET MANAGEMENT LP 10,500,000 PRN10,727,647 dollarsHigher by 5,500,000 Prior quarter: 5,000,000Open filing 0001214659-26-014366 Filed 2026-11-16 Dispute this row
GLAZER CAPITAL, LLC 10,000,000 PRN10,283 dollarsNot in the prior quarter’s filings read Open filing 0001076809-26-000174 Filed 2026-11-17 Dispute this row
Laurion Capital Management LP 7,697,272 SH43,104,723 dollarsLower by 122,741 Prior quarter: 7,820,013Open filing 0001390202-26-000018 Filed 2026-10-30 Dispute this row
STATE STREET CORP Partly reported under another manager7,596,209 SH42,538,770 dollarsHigher by 225,415 Prior quarter: 7,370,794Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
UBS Group AG Option: Call Partly reported under another manager7,330,911 SH41,053,102 dollarsHigher by 956,206 Prior quarter: 6,374,705Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Omega Fund Management, LLC 7,151,031 SH40,045,774 dollarsLower by 930,058 Prior quarter: 8,081,089Open filing 0001193125-26-462150 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager6,750,000 PRN6,862,590 dollarsHigher by 1,625,000 Prior quarter: 5,125,000Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager6,446,677 SH36,108,860 dollarsHigher by 201,872 Prior quarter: 6,244,805Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MILLENNIUM MANAGEMENT LLC 5,500,000 PRN5,626,653 dollarsLower by 2,750,000 Prior quarter: 8,250,000Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
ABSOLUTE INVESTMENT ADVISERS, LLC 5,500,000 SH5,631,142 dollarsHigher by 5,000,000 Prior quarter: 500,000Open filing 0001062993-26-005451 Filed 2026-10-21 Dispute this row
ADVENT CAPITAL MANAGEMENT /DE/ 5,347,000 PRN5,473,064 dollarsLower by 4,152,000 Prior quarter: 9,499,000Open filing 0001140361-26-042650 Filed 2026-11-09 Dispute this row
BROOKFIELD Corp /ON/ Partly reported under another manager5,250,000 PRN5,363,823 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-467250 Filed 2026-11-18 Dispute this row
LAZARD ASSET MANAGEMENT LLC 5,000,000 PRN51,084 dollarsLower by 2,000,000 Prior quarter: 7,000,000Open filing 0001207017-26-000051 Filed 2026-11-16 Dispute this row
SUSQUEHANNA ADVISORS GROUP, INC. Partly reported under another manager5,000,000 PRN50,909 dollarsUnchanged Prior quarter: 5,000,000Open filing 0001444949-26-000017 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager4,519,041 SH25,306,641 dollarsHigher by 19,398 Prior quarter: 4,499,643Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager4,511,958 SH25,266,965 dollarsHigher by 2,607,272 Prior quarter: 1,904,686Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Jones Hill Capital LP 4,486,986 SH25,127,122 dollarsNot in the prior quarter’s filings read Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row
SHENKMAN CAPITAL MANAGEMENT INC 4,000,000 PRN4,179,010 dollarsHigher by 1,000,000 Prior quarter: 3,000,000Open filing 0001275228-26-000007 Filed 2026-11-10 Dispute this row
Jefferies Financial Group Inc. Partly reported under another manager3,619,000 PRN3,734,913 dollarsLower by 11,167,000 Prior quarter: 14,786,000Open filing 0000096223-26-000034 Filed 2026-11-05 Dispute this row
CSS LLC/IL Partly reported under another manager3,543,000 PRN3,648,270 dollarsHigher by 2,543,000 Prior quarter: 1,000,000Open filing 0001103646-26-000019 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager3,500,000 PRN3,598,872 dollarsHigher by 1,500,000 Prior quarter: 2,000,000Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
Wellesley Asset Management 3,500,000 PRN2,691,701 dollarsUnchanged Prior quarter: 3,500,000Open filing 0001533551-26-000009 Filed 2026-11-12 Dispute this row
TWO SIGMA INVESTMENTS, LP 3,300,303 SH18,481,697 dollarsHigher by 2,051,894 Prior quarter: 1,248,409Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
TANG CAPITAL MANAGEMENT LLC Partly reported under another manager3,299,557 SH18,477,519 dollarsUnchanged Prior quarter: 3,299,557Open filing 0001214659-26-014410 Filed 2026-11-16 Dispute this row
Redmile Group, LLC 3,031,009 SH16,973,650 dollarsUnchanged Prior quarter: 3,031,009Open filing 0000905148-26-004923 Filed 2026-11-16 Dispute this row
CAPSTONE INVESTMENT ADVISORS, LLC Partly reported under another manager3,000,000 PRN3,065,042 dollarsUnchanged Prior quarter: 3,000,000Open filing 0001426196-26-000006 Filed 2026-11-16 Dispute this row
Ares Systematic Credit Ltd 2,800,000 PRN2,860,706 dollarsHigher by 1,800,000 Prior quarter: 1,000,000Open filing 0001104659-26-128229 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 2,619,082 SH14,666,859 dollarsLower by 69,584 Prior quarter: 2,688,666Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Connor, Clark Lunn Investment Management Ltd. 2,536,908 SH14,206,685 dollarsHigher by 780,088 Prior quarter: 1,756,820Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager2,508,296 SH14,046,457 dollarsHigher by 151,867 Prior quarter: 2,356,429Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager2,500,000 PRN2,541,750 dollarsNot in the prior quarter’s filings read Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
JACOBS LEVY EQUITY MANAGEMENT, INC 2,461,936 SH13,786,842 dollarsHigher by 1,927,177 Prior quarter: 534,759Open filing 0000884414-26-000004 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager2,371,009 SH13,277,651 dollarsHigher by 382,679 Prior quarter: 1,988,330Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager2,340,153 SH13,104,857 dollarsHigher by 18,280 Prior quarter: 2,321,873Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2,304,864 SH12,907,238 dollarsHigher by 245,994 Prior quarter: 2,058,870Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Duquesne Family Office LLC 2,269,900 SH12,711 dollarsLower by 2,269,900 Prior quarter: 4,539,800Open filing 0001536411-26-000011 Filed 2026-11-16 Dispute this row
EFG International AG Partly reported under another manager2,200,000 PRN2,247,697 dollarsHigher by 1,700,000 Prior quarter: 500,000Open filing 0002109868-26-000012 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 2,180,710 SH12,211 dollarsLower by 27,069 Prior quarter: 2,207,779Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
ARMISTICE CAPITAL, LLC 2,096,000 SH11,737,600 dollarsHigher by 96,000 Prior quarter: 2,000,000Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager2,077,406 SH11,633,478 dollarsHigher by 620,073 Prior quarter: 1,457,333Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,879,786 SH10,526,802 dollarsHigher by 103,232 Prior quarter: 1,776,554Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • D. E. Shaw Co., Inc. 27,500,000 PRN
  • Polar Asset Management Partners Inc. 25,000,000 PRN
  • JANE STREET GROUP, LLC 8,000,000 PRN
  • HIGHBRIDGE CAPITAL MANAGEMENT LLC 5,500,000 PRN
  • Nuveen, LLC 3,500,000 PRN
  • Sixth Street Partners Management Company, L.P. 2,058,870 SH
  • Murchinson Ltd. 1,500,000 PRN
  • ZAZOVE ASSOCIATES LLC 1,500,000 PRN
  • Paloma Partners Management Co 1,000,000 PRN
  • Monashee Investment Management LLC 1,000,000 PRN
  • ACT CAPITAL MANAGEMENT, LLC 520,000 SH
  • PEAK6 LLC 500,000 PRN
  • Castle Hook Partners LP 409,986 SH
  • Ishara Investments LP 369,000 SH
  • Qube Research Technologies Ltd 287,221 SH
  • QVT Financial LP 170,794 SH
  • VIRGINIA RETIREMENT SYSTEMS ET Al 110,000 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 109,567 SH
  • Jupiter Topco LLC 108,400 SH
  • TPG GP A, LLC 100,000 SH
  • Diametric Capital, LP 76,138 SH
  • SG Americas Securities, LLC 59,428 SH
  • Quarry LP 45,000 SH
  • Jain Global LLC 30,495 SH
  • MIRABELLA FINANCIAL SERVICES LLP 30,093 SH
  • MCF Advisors LLC 27,241 SH
  • WINTON GROUP Ltd 19,400 SH
  • CANADA PENSION PLAN INVESTMENT BOARD 15,500 SH
  • KEYBANK NATIONAL ASSOCIATION/OH 12,008 SH
  • STRS OHIO 4,300 SH
  • Persistent Asset Partners Ltd 2,607 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 1,700 SH
  • Aster Capital Management (DIFC) Ltd 1,420 SH
  • SALEM INVESTMENT COUNSELORS INC 1,100 SH
  • Strategic Wealth Advisors LLC 1,000 SH
  • Wealth Enhancement Trust Services, Inc. 220 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BlackRock, Inc. Common Stock6.421,708,84306/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-003099 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,598,888 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020224,461
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Nuvation Bio Inc.